Pascal Wolter

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert, Bogusława Karaszewska, Jacob Schachter et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Toward Minimal Residual Disease-Directed Therapy in Melanoma

Florian Rambow, Aljosja Rogiers, Oskar Marín-Béjar et al. · Cell · 2018 · 771 citations · Full text

Medicine, Dermatology, Oncology +12

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations

Medicine, Hematology, Oncology +12

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

Mario Sznol, Pier Francesco Ferrucci, David Hogg et al. · Journal of Clinical Oncology · 2017 · 294 citations

Pharmacy, Oncology, Pharmacotherapy +17

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Richard D. Carvajal, Sophie Piperno‐Neumann, Ellen Kapiteijn et al. · Journal of Clinical Oncology · 2018 · 275 citations · Full text

Medicine, Oncology, Pharmacology +15